SGMA
SGMA’s work has been covered by clinical research trade press, public health media, and institutional partners across the global healthcare ecosystem.
SCOPE Takeaways On Inclusion And Real Patient-Centricity
Clinical Leader · February 13, 2026
Chief Editor Dan Schell features Garo Kiledjian prominently on panel “Access = Acceleration.” Covers SGMA rebrand announcement at SCOPE.
SCOPE Summit 2025: Advancing Clinical Research Through Strategic Partnerships
ACT · February 4, 2025
Don Tracy, Associate Editor of ACT, covered SCOPE Summit 2025 and the SGMA SOGI Business Case presentation.
Finalists Announced for SCOPE's 9th Annual Participant Engagement Awards
ACT · January 3, 2025
Andy Studna, editor of ACT, announced the SCOPE PEA finalists including SGMA.
SGM Alliance Announces Call to Action to Address Representation Issues
Dallas Voice · June 20, 2024
Tammye Nash covered SGMA’s first-of-its-kind collaboration announcement with pharmaceutical organizations.
*Coverage from SGM Alliance era
Companies Working on Lifting Restrictions on HIV-Positive People in Clinical Trials
Bay Area Reporter · June 11, 2024
John Ferrannini covered SGMA’s collaboration with a perspective from Dr. Tom Uldrick, Fred Hutchinson Cancer Center.
SGM Alliance Announces Global Collaboration and Call to Action
BioSpace · June 6, 2024
BioSpace announced SGMA’s inaugural collaboration with Eli Lilly, Gilead, Pfizer, AstraZeneca, and others.
*Coverage from SGM Alliance era
SCRS Talks — Garo Kiledjian, Founder, President & CEO, SGMA
SCRS Talks Podcast
Garo Kiledjian discusses SGMA’s methodology, the case for population-complete ascertainment, and what standards infrastructure means for clinical research.
#StopTheCopyPaste
Founding Campaign
SGMA’s flagship campaign challenging the practice of copying and pasting outdated eligibility language into clinical research protocols — language that excluded people living with HIV from trials for conditions with no HIV connection.
#STDsAreNotMyOnlyHealthConcern
Founding Campaign
Community mobilization campaign highlighting that people living with HIV and SGM populations have diverse healthcare needs beyond their primary diagnosis — and clinical research must reflect this reality.
